The Immunoassay Market is being driven by Predictive and preventive medicine for early diagnosis and treatment
The Immunoassay Market is expected to grow at a CAGR of 4.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 9.4 billion. In the agricultural sector, antibiotics are extensively utilized for disease prevention and treatment in livestock production. However, the presence of antibiotic residues in animal-derived food sources poses a significant health risk to consumers. This issue of food contamination with antibiotic residues is a pressing global concern due to the rampant and unregulated use of antibiotics in animal husbandry. Immunoassays, a biochemical technique based on the interaction between specific antigens and antibodies, offer a promising solution for the detection and monitoring of antibiotic residues in food and environmental samples. With their simplicity in sample preparation and highly sensitive detection capabilities, immunoassays are increasingly being adopted for the screening of antibiotic residues in food testing. Consequently, the growing demand for immunoassays in food safety and quality control is anticipated to fuel the expansion of the immunoassay market during the forecast period.
Get more information on Immunoassay Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
204 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.6% |
Market growth 2025-2029 |
USD 9.4 billion |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
4.0 |
Key countries |
US, UK, Germany, Canada, China, France, Italy, Japan, India, South Korea, UAE, Brazil, Rest of World (ROW), US, UK, Germany, Canada, China, France, Italy, Japan, India, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Immunoassay Market encompasses various technologies including Immunochromatographic Assays, Enzyme-Linked Immunosorbent Assays (ELISA), Fluorescence Polarization, Microfluidic Devices, and more. These assays are utilized in Serological Testing, Viral Load Monitoring, Antimicrobial Susceptibility Testing, Allergy Testing, Food Safety Testing, Environmental Monitoring, Forensic Science, Clinical Trial Support, Biopharmaceutical Development, Companion Diagnostics, Predictive Diagnostics, Early Disease Detection, Population Screening, Disease Management, Patient Monitoring, Clinical Decision Support, Point-of-Care Testing, Home-Based Diagnostics, and Remote Patient Management. Technological advancements in Artificial Intelligence, Machine Learning, Big Data Analytics, Cloud Computing, Internet of Things, Digital Pathology, Imaging Analysis, Sample Preparation, Sample Handling, Quality Control, Inter-Laboratory Comparison, Assay Performance, Limit of Detection, and Limit of Quantification continue to drive market growth.
In the expansive biotechnology industry, the Immunoassay Market holds a significant position, encompassing Lateral Flow Assays, Automated Immunoassay Analyzers, High-Throughput Screening, Diagnostic Tests, and Drug Discovery. This market segment falls under the broader healthcare sector, which is projected to witness substantial growth due to several factors. The aging population is a primary driver, with Europe and the US forecasted to have over 25% of their populations aged 60 and above by 2030 and 2050, respectively. This demographic shift will fuel demand for healthcare solutions, including advanced diagnostic tools and biotech reagents, thereby propelling the growth of the Immunoassay Market within the global healthcare industry.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted